The Latest Cancer Drugs News
Browsing: Cancer Drug News
Phase two CD19-antibody-drug conjugate trial demonstrates promise for aggressive lymphoma
MUSC Hollings Cancer Center (USA) was one of 28 clinical sites around the world that…
New generation anti-cancer drug shows promise for children with brain tumours
A genetic map of the aggressive childhood brain tumour medulloblastoma has helped researchers identify a…
New drug combination attacks prostate cancer on two fronts to keep men healthy for longer
Men with particularly aggressive prostate cancers can be treated more effectively by combining an existing…
EAU 2021: New use of old drug reduces risk of kidney cancer returning
Using an existing drug for late-stage kidney cancer at an earlier stage of the disease…
Novel approach yields potential drug candidate for bladder cancer
A new approach to molecular drug design has yielded a highly promising bladder cancer drug,…
European Commission approval for azacitidine tablets as frontline oral maintenance therapy for adults with acute myeloid leukaemia
Bristol Myers Squibb announced that the European Commission (EC) has granted full marketing authorisation for…
New research uncovers how cancers with common mutation develop resistance to targeted drugs
A new study by Dana-Farber Cancer Institute researchers has given scientists their first look at…
Potential drug target for difficult-to-treat breast cancer: RNA-binding proteins
In cancer research, it’s a common goal to find something about cancer cells — some…
WEHI and Boehringer Ingelheim partner to develop innovative cancer drugs
WEHI has partnered with Boehringer Ingelheim in a collaboration to discover and develop anti-cancer therapeutics…
Researchers discover a novel class of drugs that may help treat a deadly type of lymphoma
A new class of drugs that inhibits a “master switch” involved in the vast majority…